#1
|
||||
|
||||
Êàê áðîñèòü êóðèòü, âðà÷ó...
Äëÿ ìåíÿ äàííûé âîïðîñ íå áàíàëåí, è ÿ èùó íà íåãî îòâåò ïîñëåäíèå ëåò 6 - 7. Êóðþ 15 ëåò (ìíå 35), â ïîñëåäíåå âðåìÿ èíòåíñèâíîñòü 1 ïà÷êà â äåíü. Áðîñàë íåñêîëüêî ðàç, ìàêñèìàëüíî íà 5 - 7 ìåñÿöåâ. Ãðàôèê æèçíè ðâàííûé, ðàáîòà âðåäíàÿ, ñàì ÷åëîâåê ñëàáîâîëüíûé.
åñëè êòî-òî ïîìîæåò, ïî ãðîá áóäó áëàãîäàðåí... |
#2
|
||||
|
||||
Îòëè÷íàÿ ïðîáëåìà, êîëëåãà! ( è ïî êóðåíèþ òàê æå).
 ïîèñêàõ îòâåòà íà ýòîò âîïðîñ ÿ çà ãîä ïåðåðûë âåñü èíåò, óô.. Ïî ìåäèêàìåíòàì ìîæíî ïîñìîòðåòü òóò - [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Èç äîñòàòî÷íî íîâîãî - àíòèäåïðåññàíò çóáàí ( åñëè íóæíî ïîøëþ àíîòàöèþ) Äàâàéòå èñêàòü ïîäõîä. Ó Âàñ âñå-òàêè ïîëó÷àåòñÿ áîëüøå ïîëóãîäà, à ó ìåíÿ 1-2 äíÿ È âîîáùå áóäó ðàä ëþáîé èíôîðìàöèè ïî ýòîé òåìå!!!!!!!!!!!!!!!!!
__________________
Ñ óâàæåíèåì Âëàäèìèð Ìèõàéëîâè÷ Ïîäêîëçèí |
#3
|
||||
|
||||
29 íîÿáðÿ 2004 ã. Ïîïûòêà áðîñèòü êóðèòü îêàçûâàåòñÿ óñïåøíîé íå áîëåå ÷åì â òðåòè ñëó÷àåâ. Ïîâûñèòü ýôôåêòèâíîñòü ëå÷åíèÿ ìîæåò êîìïëåêñíûé ïîäõîä â ëå÷åíèè ýòîé ñëîæíîé è õðîíè÷åñêîé çàâèñèìîñòè, ñ÷èòàþò ó÷åíûå èç Óíèâåðñèòåòà Êàëèôîðíèè, Ñàí-Ôðàíöèñêî, ÑØÀ.
Èñïîëüçóÿ ìîäåëü õðîíè÷åñêîé áîëåçíè êóðåíèÿ, àâòîðû ïðîâåëè èçó÷åíèå äîëãîñðî÷íûõ ýôôåêòîâ àíòèäåïðåññàíòîâ è ïñèõîòåðàïèè.  èññëåäîâàíèè ïðèíÿëè ó÷àñòèå 160 ÷åëîâåê, âûêóðèâàþùèõ 10 è áîëåå ñèãàðåò â äåíü. Îíè áûëè ðàçáèòû íà ÷åòûðå ýêñïåðèìåíòàëüíûå ãðóïïû. Ïåðâûé ýòàï ëå÷åíèÿ â òå÷åíèå 8 íåäåëü ïðîøëè âñå ïàöèåíòû. Íà ôîíå ïðèìåíåíèÿ íîðòðèïòèëèíà èëè ïëàöåáî îáñëåäóåìûå èñïîëüçîâàëè íèêîòèíîâûå ïëàñòûðè è ïîëó÷àëè êîíñóëüòàöèè ñïåöèàëèñòîâ. Âòîðîé ýòàï ëå÷åíèÿ, êîòîðûé ïðîäîëæèëè òîëüêî äâå ãðóïïû, âêëþ÷àë ïðèåì íîðòðèïòèëèíà èëè ïëàöåáî â òå÷åíèå 52 íåäåëü, ñîâìåùåííûé ñ äåâÿòèìåñÿ÷íîé ïñèõîòåðàïèåé. ×åðåç 52 íåäåëè óðîâåíü âîçäåðæàíèÿ îò êóðåíèÿ ó ïàöèåíòîâ, ïðîøåäøèõ äîëãîñðî÷íûé òåðàïåâòè÷åñêèé êóðñ, áûë â 2,5 ðàçà âûøå, ÷åì ó òåõ, êòî ïðîøåë òîëüêî ïåðâûé ýòàï ëå÷åíèÿ, è ñîñòàâèë 56%. "Îïèñàííûå ðàíåå ìåòîäû ëå÷åíèÿ íå ïîçâîëÿþò äîáèòüñÿ áîëåå 35% èçáàâëåíèÿ îò òàáà÷íîé çàâèñèìîñòè. Ïîëó÷åííûå â äàííîì èññëåäîâàíèè ðåçóëüòàòû ñâèäåòåëüñòâóþò î òîì, ÷òî ñîâìåùåíèå ôàðìàêîëîãè÷åñêîãî è ïñèõîëîãè÷åñêîãî ïîäõîäà ïîâûøàåò ýôôåêòèâíîñòü òåðàïèè", çàêëþ÷àþò S.M.Hall è ñîàâòîðû íà ñòðàíèöàõ æóðíàëà The American journal of psychiatry. Èñòî÷íèê: Vertigo.ru
__________________
Ñ óâàæåíèåì Âëàäèìèð Ìèõàéëîâè÷ Ïîäêîëçèí |
#4
|
|||
|
|||
Öèòàòà:
|
#5
|
||||
|
||||
Ýõ, Àëåêñåé êàê æå Âû íå ïðàâû.
Åñëè áû òîëüêî ðóíåò.... îò Êèòàÿ äî Àëÿñêè Íàðêîëîãèÿ - ìîÿ îñíîâíàÿ ñïåöèàëüíîñòü è ìåíÿ åñòåñòâåííî óäðó÷àåò îòñóòñòâèå îáîñíîâàííîé òåðàïèè íàðêîëîãè÷åñêèõ çàáîëåâàíèé. Áåäà äàæå è íå â ýòîì. Ìû íàðêîçàâèñèìûå! È êàê ÂÑÅ íàðêîçàâèñèìûå èùåì âîëøåáíèêà, êîòîðûé ïðèäåò, âçìàõíåò è ÷òî òàì åùå âîëøåáíèêè äåëàþò, è ÿ ïîìîëîäåþ, çàäûøó ïîëíûìè ëåãêèìè, ïåðåñòàíó êàøëÿòü, èñ÷åçíåò îòäûøêà è ïðîïàäåò ÒßÃÀ. Òàê òî. Ãðóñòíî, íî ïîìî÷ü áðîñèòü êóðèòü êîìó òî ÿ ìîãó, à âîò ñåáå.... ß îñîçíàþ, ÷òî åñëè ìû âñå çàéìåìñÿ ïðîôèëàêòèêîé ýòîãî äåëà, òî âîçìîæíî íàøè äåòè íå áóäóò êóðèòü ( çàìåòüòå, àêöåíòèðóþ íà êóðåíèè!!) Íà ôîðóìå, ÿ íåîäíàêðàòíî ïûòàëñÿ ïðèâëå÷ü âíèìàíèå ê ýòîé ïðîáëåìå, óâû. Ìåæäó òåì òàáàê - ïåðâûé íàðêîòèê ñ êîòîðûì ñòàëêèâàåòñÿ ðåáåíîê. Åñòü ìíîãî èíòåðåñíûõ ðàáîò, êàñàþùèõñÿ âîñïðèÿòèþ òàáàêîêóðåíèÿ äåòåé 5- 6 ëåòíåãî âîçðàñòà. Âîçìîæåí è ïðîãíîç àääèêòèâíîãî ïîâåäåíèÿ. À ãàçåòíûå çàòðàâêè - ÷åì ïëîõè?
__________________
Ñ óâàæåíèåì Âëàäèìèð Ìèõàéëîâè÷ Ïîäêîëçèí |
#6
|
||||
|
||||
Öèòàòà:
Ïîñåùàë ñïåöèàëüíó ëåêöèþ, ïðè÷åì äëÿ âðà÷åé. Ïîñëå íåå òðè ìåñÿöà æèë ñ ïðèêëååííûì íèêîòèíîâûì ïëàñòûðåì, íà êîòîðûé ó ìåíÿ (ÿ íå àëëåðãèê) ðàçâèëàñü íåïðèÿòíàÿ àëëåðãè÷åñêàÿ ðåàêöèÿ, ñòîèëî ìíå íàêëåèòü ïëàñòûðü ÷åðåç ìèíóò ïÿòíàäöàòü - ãèïèðåìèÿ, ðåçü, íà êîæå ïîòîì êîðî÷êè. Ïîñëå ýòîãî îïÿòü çàêóðèë, íî êóðèë óæå ïî äâå ïà÷êè â äåíü, ìàëî òîãî ïåðâûå äâå íåäåëè êóðèë ñèãàðû (÷òî áû êàê òî "íàêóðèòüñÿ"). Ïëàñòûðü áûë ñðåäíèé, à ïîñëåäíèå äâå íåäåëè âîáùå ïåðâûé (ñ íèçêèì ñîäåðæàíèåì). |
#7
|
||||
|
||||
À î çóáàíå?
__________________
Ñ óâàæåíèåì Âëàäèìèð Ìèõàéëîâè÷ Ïîäêîëçèí |
|
#8
|
||||
|
||||
ëå÷åíèå ( ïîäáîðêà)
__________________
Ñ óâàæåíèåì Âëàäèìèð Ìèõàéëîâè÷ Ïîäêîëçèí |
#9
|
||||
|
||||
Äëÿ ðàçðÿäêè àòìîñôýðû...
Áåñïëàòíûé ýïèäóðèò
À. Ñòðàæíûé .: Äàòà ïóáëèêàöèè 06-Àïð-2004 Âðà÷è ëþáÿò ñòàâèòü äèàãíîçû. Åñëè âàñ íè÷åãî íå áåñïîêîèò — ýòî íå âàæíî. Âñ¸ ðàâíî âû ñòðàäàåòå ïëîñêîñòîïèåì, îñòåîõîíäðîçîì ñ èñêðèâëåíèåì, âåãåòî-ñîñóäèñòîé äèñòîíèåé, ôîáè÷åñêèì íåâðîçîì, ñåáîðååé (ïåðõîòüþ) è ïðåä- êàêèì-íèáóäü ñîñòîÿíèåì. ×òî, íåòó? Òîãäà àñòåíè÷åñêèé ñèíäðîì, ñëèøêîì óçêèé (øèðîêèé) òàç, óãðè, ãåìîððîé, áëèçîðóêîñòü. À áóäåòå äàëüøå ñîïðîòèâëÿòüñÿ, ïîëó÷èòå ñâèù ðåêòîâåñòèáóëÿðíûé, ôóíêöèîíàëüíûé ñòðèäîð (äà-äà!) èëè áîëåçíü Øåíëåéí-Ãåíîõà. Ó÷àñòêîâûé òåðàïåâò íåïðåìåííî íàéä¸ò ó âàñ (è äàæå íå ïûòàéòåñü åìó âòîëêîâàòü, ÷òî âû äàâíî íå òðàõàëèñü) òðàõåèò. Äëÿ íàñ, âðà÷åé, ÿ áû äàæå ïàìÿòêó ñîñòàâèë, ÷òî çàïèñûâàòü â ãðàôó “äèàãíîç” â çàòðóäíèòåëüíûõ ñëó÷àÿõ: ðîæà (ó êîãî å¸ íåò?), õðîíè÷åñêèé àëêîãîëèçì (âñå ïüþò “êàê âñå”), àòðåçèÿ àíóñà (÷¸ðò çíàåò ÷òî òàêîå, íî çâó÷èò êðàñèâî), îæèðåíèå (ó õóäûõ — îñòðûé æèâîò), âðîæä¸ííàÿ êîñîëàïîñòü, èñêðèâëåíèå áîëüøîãî ïàëüöà ñòîïû êíàðóæè, îïóùåíèå âåðõíåãî âåêà, òðåïåòàíèå æåëóäî÷êà (êóøàòü-òî õî÷åòñÿ). À åñëè ïàöèåíò ïðîñïàë íà ðàáîòó è ïðèø¸ë ñ ìàãàðû÷îì çà “áîëüíè÷íûì” — ïðîëåæåíü. Ïîïðîáóéòå ìåäïåðñîíàëó äîêàçàòü, ÷òî âû âðåìÿ îò âðåìåíè íå ñòðàäàåòå ïî÷åñóõîé, çàäåðæêîé ìî÷è îñòðîé, áåøåíñòâîì, èäèîòèçìîì, àñòåíîãåíèòàëüíûì ñèíäðîìîì èëè ñòîëáíÿêîì âóëüãàðíûì ñ òàõèêàðäèåé (åñëè âû ìóæ÷èíà), èñòåðèåé, âîë÷àíêîé èëè ðàññåÿííûì ñêëåðîçîì (æåíùèíà). Ñàìûõ óïîðíûõ ìîæíî ïðèïóãíóòü äèàãíîçàìè: áóëåìèÿ (îáæîðñòâî), çîîôèëèÿ, ÿùóð, ýïèäóðèò (íå øó÷ó, è òàêîé èìååòñÿ). Âîò è ìíå, êàê ïàöèåíòó, ïðèøëîñü ñòîëêíóòüñÿ ñ òàêîé ëþáîâüþ âðà÷åé ê äèàãíîçàì. Äëÿ îôîðìëåíèÿ çàãðàíêîìàíäèðîâêè ïîòðåáîâàëîñü ïðîéòè ìåäîñìîòð. Ñîáñòâåííî, ìåíÿ áû è áåç ìåäîñìîòðà âûïóñòèëè — ïðîñòî ðåøèë, íà âñÿêèé ñëó÷àé, îôîðìèòü òàêæå è ìåäèöèíñêóþ ñòðàõîâêó, à äëÿ íå¸ íóæíû áûëè ñïðàâêè èç ïîëèêëèíèêè. ß è çà ãðàíèöåé ìîã áû èõ ïîëó÷èòü, íî òàì — çà ãóëüäåíû, à çäåñü, â ðîäíîé ïîëèêëèíèêå, áåñïëàòíî. Ñäàë àíàëèçû, ñäåëàëè ìíå ôëþîðîãðàôèþ — âñ¸ â ïîðÿäêå. Íà ñëåäóþùèé äåíü ïîëó÷àþ ðàñøèôðîâêó ÝÊÃ: “Âðîæä¸ííàÿ äåêñòðàêàðäèÿ, íàðóøåíèå âîçáóæäåíèÿ â ïðåäñåðäèÿõ (íå óøèðåííûé, íî âûñîêèé çóáåö Ð), óäëèí¸ííàÿ âíóòðèæåëóäî÷êîâàÿ ïðîâîäèìîñòü, àñèíõðîííîå ïîðàæåíèå ìèîêàðäà”. Âîò ýòî äà! ×òî çà ÷óøü — ñåðäöå âåäü íèêîãäà íå áåñïîêîèëî! Õîòÿ, ÷¸ðò âîçüìè, íà÷èíàþ ïðèïîìèíàòü — òàêè ïîáàëèâàëî... — À ìîæíî, — ñïðàøèâàþ â ðåãèñòðàòóðå, — ñ äîêòîðîì ïîãîâîðèòü, êîòîðàÿ ìíå êàðäèîãðàììó ñíèìàëà? (Ñàì-òî ÿ ïñèõèàòð, äàâíî çàáûë ÷òî îçíà÷àþò âñå ýòè ñåðäå÷íûå çàâèòóøêè). — Îíà íå ïðèíèìàåò, çàïèñûâàéòåñü ê êàðäèîëîãó. Íî îí â îòïóñêå, âûéäåò íåäåëè ÷åðåç òðè, — îòâå÷àþò. Äîæèâó ëè?.. Ïîáåæàë (íåò-íåò, ïîø¸ë ÷óòü äûøà!) â “Ìåäêíèãó”, êóïèë ñïðàâî÷íèê ïî ÝÊÃ. È âîò ÷òî îí ìíå ïîâåäàë: “Ýëåêòðîêàðäèîãðàììû ñ âðîæä¸ííîé äåêñòðàêàðäèåé, íàðóøåíèåì âîçáóæäåíèÿ â ïðåäñåðäèÿõ, óäëèí¸ííîé âíóòðèæåëóäî÷êîâîé ïðîâîäèìîñòüþ è àñèíõðîííûì ïîðàæåíèåì ìèîêàðäà íàáëþäàþòñÿ ïðè ðÿäå çàáîëåâàíèé, à èìåííî: ïîðîêå ñåðäöà, ðåçêîé ñòåïåíè ýìôèçåìû ë¸ãêèõ, ýìáîëèè èëè ñóæåíèè ëåãî÷íîé àðòåðèè, à òàê æå ïðè ñèôèëèòè÷åñêîì àîðòèòå”. “Èíòåðåñíî — ìåëüêíóëà ìûñëü, — à ÷òî ïîêàæåò âñêðûòèå? Ñðàìó-òî ñêîëüêî — ïîìåðåòü îò ñèôèëèòè÷åñêîãî àîðòèòà!” Êîðî÷å, ñ êóðåíèåì çàâÿçàë â òîò æå äåíü. À òóò è ñåðäöå ðàñøàëèëîñü, íîåò, è îäûøêà îòêóäà íè âîçüìèñü ïîÿâèëàñü. Ãðóäíàÿ æàáà, çíàåòå ëè. ßâëÿþñü ÷åðåç òðè íåäåëè ê êàðäèîëîãó (êòî æå ñ òàêèì äèàãíîçîì çà ãðàíèöó ïîåäåò?) Ãëÿíóë âðà÷ íà ìîþ ÝÊà è ñïðàøèâàåò: — À Âû ÷åãî, ñîáñòâåííî, ïðèøëè? Ó Âàñ íîðìàëüíàÿ êàðäèîãðàììà. (Ôó, îòëåãëî, è ñåðäöå ñðàçó áîëåòü ïåðåñòàëî). — À êàê æå óøèðåííûé çóáåö Ð ñ ñèôèëèòè÷åñêèì àîðòèòîì? — íåäîóìåâàþ. — À, áðîñüòå. Ýòî íàøà ïåäèàòð èç äåêðåòà âûøëà, à âñå äîëæíîñòè äåòñêèõ âðà÷åé çàíÿòû. Òàê ìû å¸ ïîñàäèëè ÝÊà ðàñøèôðîâûâàòü. È ýòî æ ñêîëüêî íàðîäó êóðèòü ïîõåðèëî çà òî âðåìÿ, ÷òî îíà òàì ñèäèò! Íå æåëàåòå ëè? Ðåêîìåíäóþ: óëèöà Ãðåòû Âîðîïàåâîé 104, òðåòèé ýòàæ. Áåñïëàòíî. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Lead, follow, or get out of the way. — Thomas Paine |
#10
|
||||
|
||||
Öèòàòà:
|
#11
|
|||
|
|||
Ãîâîðÿò, ÷òî êóðèòü áðîñèòü ìîãóò òîëüêî òå, êòî äåéñòâèòåëüíî ýòîãî õîòÿò. Îäèí äîöåíò íàøåé êàôåäðû, êóðÿùèé ïî 2 ïà÷êè â äåíü, ïîñëå èíôàðêòà áðîñèë è íå êóðèò óæå 2 ãîäà. Áóäåòå æäàòü âåñîìóþ ïðè÷èíó èëè òàê áðîñèòå !??!!
Ñîâåòóþ Âàì çàíÿòüñÿ ñïîðòîì, æåëàòåëüíî îðèåíòèðîâàííûì íà õîðîøèé æèíåííûé îáúåì ëåãêèõ: áåã, ôóòáîë, áàñêåòáîë, âåëîñèïåä, àýðîáèêà èëè åå ðàçíûå âàðèàíòû. Ïîñëå õîðîøåé àýðîäèíàìè÷åñêîé íàãðóçêè êóðèòü â ïðèíöèïå òÿæåëî. |
#12
|
|||
|
|||
Äîêòîð Õàáàðîâ, íåäàâíî ñëóøàë íà ëåêöèþ ïðî âíóòðèñîñóäèñòûé óëüòðàçâóê... Ãîâîðÿò, ÷òî ò.í. ýêñòðàâàçàëüíûå õîëåñòåðèíîâûå áëÿøêè îáíàðóæèâàþòñÿ â 20 ëåò ó 17% ëþäåé. Ñ âîçðàñòîì çíà÷èòåëüíî âûøå. Åñ-íî, ïðè íåñòàáèëüíîñòè òàêèå áëÿøêè ïðèâîäÿò ê îáðàçîâàíèþ òðîìáîâ è ðàçâèòèþ èíôàðêòîâ, íî íå îáíàðóæèâàþòñÿ ïðè àíãèîãðàôèè. Íå ìîãëè áû Âû âûñêàçàòüñÿ íà òåìó â êîíòåêñòå âðåäà êóðåíèÿ è ðàçâèòèÿ àòåðîñêëåðîçà?
|
#13
|
||||
|
||||
Âñå è òàê äîñòàòî÷íî ÿñíî ïî ïîâîäó âðåäà è ðèñêà êóðåíèÿ. Íî îãëÿíèòåñü âîêðóã, ñêîëüêî âðà÷åé, âàøèõ êîëëåã ñòðàäàþò ýòîé ïàãóáíîé ïðèâû÷êîé.
Íà ñ÷åò áðîñàíèÿ ÿ â êóðñå, ñàì ýòî äåëàë è íå ðàç óâû ðåöèäèâû çàìó÷èëè. Äà è åñëè ãîâîðèòü îòêðîâåííî, òî ïðîãíîç æèçíè ëþáîãî õèðóðãà äîñòàòî÷íî ïåññèìèñòè÷åí. Ëþáàÿ îïåðàöèÿ ýòî ñòðåññ, è íå ïîíÿòíî ÷òî õóæå, 5 – 10 ñòðåññîðíûõ ñèòóàöèé â òå÷åíèè ÷åòûðåõ ÷àñîâîé îïåðàöèè èëè ÷àøêà ÷àÿ (à ÷àñòî êîôå) ñ îäíîé äâóìÿ ñèãàðåòàìè ïîñëå.  îäèí èç äëèòåëüíûõ ïåðèîäîâ áðîñàíèÿ, âñå âðåìÿ ïîñëå îïåðàöèÿ è äî ïðèíèìàë êîíòðàñòíûé äóø, ïî ñîâåòó îäíîãî óâàæàåìîãî ìíîé âðà÷à. Ïîìîãàëî, íî ìûñëè î òîì ÷òî «ÊÓÐÈÒÜ ÍÅËÜÇß» ïðîñòî èçâîäèëè ñâîåé íàâÿç÷èâîñòüþ. Ó ìåíÿ îòåö áðîñèë ñàì â 35 ëåò è áîëüøå íèêîãäà íå êóðèë, ìàòü êóðèò äî ñèõ ïîð. ß â îáùåì òî âñå òàêè íàäåþñü ïîâòîðèòü âàðèàíò îòöà. Öèòàòà:
Ïî ïîâîäó ýêñòðàâàçàëüíûõ áëÿøåê õîðîøèå ïóáëèêàöèè ó ïðîôåññîðà Ýðáåëÿ. Öèòàòà:
|
#14
|
||||
|
||||
Óâàæàåìûé Âèòàëèé!
Ïðàâäà, ýòî ïîêà íå ñîâñåì àêòóàëüíî, íî ïîõîæå â 2005 ãîäó ïîÿâèòñÿ íîâûé ïðåïàðàò, êîòîðûé ïîìîãàåò íå òîëüêî áðîñèòü êóðèòü, íî è íå íàáèðàòü âåñ â "ïðîñåññå áðîñàíèÿ": Positive results from 2 phase III studies of an investigational drug in a new class called selective CB 1 blockers suggest that rimonabant is an effective treatment for smoking cessation, weight loss, and metabolic syndrome risk factors. The results from the STudies with Rimonabant And Tobacco Use (STRATUS-US) and the Rimonabant In Obesity (RIO-Lipids) study were presented here on March 9th during a late-breaking clinical trials session at the American College of Cardiology 53rd Annual Scientific Sessions. Dr. Anthenelli, who reported the STRATUS-US results, said rimonabant has the potential to be the first drug to treat the 2 major risk factors for heart disease -- smoking and obesity. The study involved 11 clinical trial sites in the United States, where 787 smokers were recruited. The researchers randomized 262 patients to 5 mg rimonabant, 261 patients to 20 mg, and 264 to placebo. The average age of smokers was 42 and most had smoked about a pack a day for 11 to 24 years, said Dr. Anthenelli. The study lasted 10 weeks and the subjects were permitted to smoke during the first 2 weeks, but were asked to abstain after that. Subjects who were completely smoke-free during the last 4 weeks of the study, as verified by blood cotinine levels and by carbon monoxide levels in the breath, were considered treatment successes. About one quarter of the 20 mg rimonabant cohort kicked the smoking habit in 10 weeks, which was "about twice the quit rate seen in the placebo arm," said Dr. Anthenelli. This quit rate is slightly better than current smoking cessation aids such as nicotine gum or transdermal nicotine replacement. "These smokers quit without gaining weigh, and some even lost weight," Dr. Anthenelli also said. Smokers in the 20 mg of rimonabant cohort who were of normal weight at baseline gained no weight, while normal weight smokers taking placebo gained about 2 lbs (0.9 kg). Overweight and obese smokers in the 20 mg of rimonabant group lost 1 lb (0.45 kg) compared to an increase of 1 lb and 3 lbs (1.35 kg), respectively, in overweight and obese smokers given placebo. "And they lost weight without changing diet or increasing exercise," said Dr. Anthenelli. Ïîäðîáíåå îá ýòîì ïðåïàðàòå: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#15
|
||||
|
||||
Óâàæàåìûé Àëåêñåé!
Åñëè áóäåò èíòåðåñíûì êîëè÷åñòâåííîå âûðàæåíèå: Association of smoking with atherosclerosis In the abdominal aorta, smoking was associated with more extensive fatty streaks in the 15–24-y age group and with 3-fold more extensive raised lesions in the aorta in the 25–34-y age group (74). Smoking was also associated with a greater population of macrophage foam cells in atherosclerotic lesions (79). Èç Am J Clin Nutr. 2000 Nov;72(5 Suppl):1307S-1315S. Origin of atherosclerosis in childhood and adolescence. McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP. Íà âñÿêèé ñëó÷àé èñòî÷íèêè: 74. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP, PDAY Research Group. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol 1997;17:95–106 79. Botti TP, Amin H, Hiltscher L, Wissler RW, PDAY Research Group. A comparison of the quantitation of macrophage foam cell populations and the extent of apolipoprotein E deposition in developing atherosclerotic lesions in young people: high and low serum thiocyanate groups as an indication of smoking. Atherosclerosis 1996;124:191–202. |